Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052026 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure
A Phase 3 study, sponsored by Shaddy, Robert, M.D..
- Completed
- Registry status
- Phase 3
- Development phase
- 161
- Enrollment target
NCT00052026 is a Phase 3 study that has completed, run by Shaddy, Robert, M.D.. The registered enrollment target is 161 participants.
The verdict
NCT00052026, a Phase 3 study, has completed, sponsored by Shaddy, Robert, M.D..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 161 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new medicine, called carvedilol, improves symptoms and heart function in children who have congestive heart failure (diminished function of their heart muscle that pumps blood to the body). To accomplish this, we will give carvedilol to some patients who have diminished heart function and congestive heart failure and see whether symptoms and heart function are better at the end of an 8 month period in those who received carvedilol compared to the other patients who did not receive carvedilol. We will be testing 2 different doses of carvedilol compared to no additional medicine.
Interventions
- DRUG placebo
- DRUG carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2000-05 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052026
The ClinicalTrials.gov registry entry for NCT00052026 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shaddy, Robert, M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00052026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00052026 about?
NCT00052026 is a clinical study titled "Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure". The purpose of this study is to determine whether a new medicine, called carvedilol, improves symptoms and heart function in children who have congestive heart failure (diminished function of their heart muscle that pumps blood to the body). To accomplish this, we will give carvedilol to some patien...
What is the current status of trial NCT00052026?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 161 participants. The study started on 2000-05. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00052026?
The interventions under investigation include: placebo (DRUG), carvedilol (DRUG).
Who is sponsoring clinical trial NCT00052026?
This trial is sponsored by Shaddy, Robert, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.